Get started
BIO-RAD LABORATORIES INCBIO-RAD LABORATORIES INCBIO-RAD LABORATORIES INC

BIO-RAD LABORATORIES INC

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

BUWA chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪7.76 B‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−9.58EUR
Net income (FY)
‪−577.42 M‬EUR
Revenue (FY)
‪2.42 B‬EUR
Shares float
‪19.68 M‬
Beta (1Y)
1.64

About Bio-Rad Laboratories, Inc.

Sector
Health Technology
Industry
Medical Specialties
CEO
Norman D. Schwartz
Website
bio-rad.com
Headquarters
Hercules
Employees (FY)
‪8.03 K‬
Founded
1952
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BUWA is 276.80 EUR — it has increased by 2.44% in the past 24 hours. Watch BIO-RAD LABORATORIES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange BIO-RAD LABORATORIES INC stocks are traded under the ticker BUWA.
BUWA stock has risen by 5.77% compared to the previous week, the month change is a 2.36% fall, over the last year BIO-RAD LABORATORIES INC has showed a 20.69% decrease.
We've gathered analysts' opinions on BIO-RAD LABORATORIES INC future price: according to them, BUWA price has a max estimate of 409.33 EUR and a min estimate of 279.09 EUR. Watch BUWA chart and read a more detailed BIO-RAD LABORATORIES INC stock forecast: see what analysts think of BIO-RAD LABORATORIES INC and suggest that you do with its stocks.
BUWA reached its all-time high on Nov 18, 2021 with the price of 700.00 EUR, and its all-time low was 248.50 EUR and was reached on May 9, 2024. View more price dynamics on BUWA chart.
See other stocks reaching their highest and lowest prices.
BUWA stock is 2.55% volatile and has beta coefficient of 1.64. Track BIO-RAD LABORATORIES INC stock price on the chart and check out the list of the most volatile stocks — is BIO-RAD LABORATORIES INC there?
Today BIO-RAD LABORATORIES INC has the market capitalization of ‪7.71 B‬, it has increased by 0.65% over the last week.
Yes, you can track BIO-RAD LABORATORIES INC financials in yearly and quarterly reports right on TradingView.
BIO-RAD LABORATORIES INC is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
BUWA earnings for the last quarter are 2.12 EUR per share, whereas the estimation was 1.99 EUR resulting in a 6.69% surprise. The estimated earnings for the next quarter are 1.79 EUR per share. See more details about BIO-RAD LABORATORIES INC earnings.
BIO-RAD LABORATORIES INC revenue for the last quarter amounts to ‪566.08 M‬ EUR despite the estimated figure of ‪573.76 M‬ EUR. In the next quarter revenue is expected to reach ‪588.71 M‬ EUR.
BUWA net income for the last quarter is ‪355.81 M‬ EUR, while the quarter before that showed ‪316.84 M‬ EUR of net income which accounts for 12.30% change. Track more BIO-RAD LABORATORIES INC financial stats to get the full picture.
No, BUWA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 16, 2024, the company has ‪8.03 K‬ employees. See our rating of the largest employees — is BIO-RAD LABORATORIES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIO-RAD LABORATORIES INC EBITDA is ‪526.38 M‬ EUR, and current EBITDA margin is 21.57%. See more stats in BIO-RAD LABORATORIES INC financial statements.
Like other stocks, BUWA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIO-RAD LABORATORIES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIO-RAD LABORATORIES INC technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIO-RAD LABORATORIES INC stock shows the sell signal. See more of BIO-RAD LABORATORIES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.